Building on technologies developed in the stem cell research labs of UCSF, EndoCrine is looking to commercialize a better way to discover and develop drugs. Specifically, the startup is hoping to improve diabetes treatment beyond standard insulin injections.
“EndoCrine’s proprietary human stem cell-derived islet platform revolutionizes the drug discovery and development process, saving years of time and millions of dollars usually spent by pharma companies,” CEO Gopika Nair said in a statement offered to TechCrunch. “Our innovative solution opens an exciting era of personalized medicine in diabetes.”
The company says SkyDeck helped it take the earliest steps out of the lab and into startup mode.
NuPort Robotics is among the most mature of the 17 startups included here. In fact, in mid-March,
With 17 startups participating, Berkeley SkyDeck’s Demo Day isn’t the largest cohort we’ve seen by any stretch. The collection of companies is, however, defined by a wide range of focuses, from pioneering diabetes treatments to retrofitting autonomous trucking, curated by the SkyDeck’s small team and a number of advisors.
Founded in 2012, the accelerator is focused on developing early-stage companies tied to the University of California system. Applicants must be affiliated with either one of the 10 UC schools or their national laboratories in Berkeley, Livermore and Los Alamos. Notable alumni include micromobility unicorn, Lime, and delivery robotics firm, Kiwi.
In 2020, SkyDeck — along with much of the rest of the world — went virtual.
“While flight restrictions did cause some international founders to pull crazy hours from our home countries to participate in the sessions, virtual sessions allowed additional members of our teams to participate that would otherwise not have been able to do so,” the accelerator’s organizers said in a TechCrunch post last year. “We are also hearing chatter that Demo Day will be larger than ever before because virtual events are much more scalable.”
Attending a remote startup accelerator is absolutely worth it
Highlights from Berkeley SkyDeck’s virtual demo day Image Credits: EndoCrine Bio, Inc. Building on technologies developed in the stem cell research labs of UCSF, EndoCrine is looking to commercialize a better way to discover and develop drugs. Specifically, the startup is hoping to improve diabetes treatment beyond…
Scientists find new way to reduce diabetes-related eye disease In a new study from Indiana University, researchers found that early treatment with anti-VEGF injections reduces diabetic retinopathy. Their 2-year results suggest that close monitoring and routine treatment when complications develop are key to preventing vision loss from diabetic retinopathy.…